Something to consider......
Keytruda is now leading the I/O revolution albeit with sub-optimal results.....
If (big if) efti can prove itself as a compatible aid to keytruda to improve
its results meaningfully the value of Immutep will skyrocket......Tacti=mel
has given an early indication of working well with keytruda which no doubt
in my mind influenced Merck to collaborate in US trials.....We still need
more data to convince the market though......
Also.....
I reckon Immutep are at the newsmakers conference to interest venture
capalists on a cash injection,,,,IMO it's a good idea to do this sort of thing
whilst you have ample funding so as not appear desperate and thus open
to being taken advantage of.....
This company is making all the right moves, both business and research
wise.....
Something to consider......Keytruda is now leading the I/O...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
